Use of non-steroidal anti-inflammatory drugs and risk of Parkinson's disease: nested case-control study.
about
The promise of neuroprotective agents in Parkinson's diseaseNon-steroidal anti-inflammatory drugs as disease-modifying agents for Parkinson's disease: evidence from observational studiesInsights into Neuroinflammation in Parkinson's Disease: From Biomarkers to Anti-Inflammatory Based TherapiesNeuroinflammation in the pathophysiology of Parkinson's disease and therapeutic evidence of anti-inflammatory drugsApplications of SPR for the characterization of molecules important in the pathogenesis and treatment of neurodegenerative diseasesAdult hippocampal neurogenesis in Parkinson's disease: impact on neuronal survival and plasticityRole of prostaglandins in neuroinflammatory and neurodegenerative diseasesDiapocynin prevents early Parkinson's disease symptoms in the leucine-rich repeat kinase 2 (LRRK2R¹⁴⁴¹G) transgenic mouse.Antihypertensive agents and risk of Parkinson's disease: a nationwide cohort studyBaseline C-Reactive Protein Levels and Life Prognosis in Parkinson Disease.Eicosanoid receptor subtype-mediated opposing regulation of TLR-stimulated expression of astrocyte glial-derived neurotrophic factor.Inflammation and clinical presentation in neurodegenerative disease: a volatile relationship.Non-steroidal anti-inflammatory drug use and functional outcome from ischemic cerebral events among women.Mitochondrial DNA and inflammatory diseases.Parkinson's disease: evidence for environmental risk factors.Glia and mast cells as targets for palmitoylethanolamide, an anti-inflammatory and neuroprotective lipid mediator.Regulation by glycogen synthase kinase-3 of inflammation and T cells in CNS diseasesl-DOPA-induced dyskinesia in Parkinson's disease: Are neuroinflammation and astrocytes key elements?Peripheral immune tolerance alleviates the intracranial lipopolysaccharide injection-induced neuroinflammation and protects the dopaminergic neurons from neuroinflammation-related neurotoxicity.Updates on immunity and inflammation in Parkinson disease pathology.CCAAT/enhancer binding protein β regulates prostaglandin E synthase expression and prostaglandin E2 production in activated microglial cells.Preceding pain symptoms and Parkinson's disease: a nationwide population-based cohort study.Nonsteroidal anti-inflammatory drugs use and risk of Parkinson disease: A dose-response meta-analysis
P2860
Q21129436-25D511E1-461E-4F64-B097-B800B40D5FE3Q24235107-5D69FDC2-5294-4B54-852D-49DB7C47C057Q26795984-46AA7568-192C-4A44-AF9F-AFA3EC6ED478Q26801035-DF543E9B-FD65-4A59-A492-9C37C93E6D7DQ26860077-7EA4B58F-3D92-48D1-B56D-0EA9FF7E5A57Q26862840-5D6D8388-4408-42BC-9619-3E16143D743BQ26863534-0D6C3269-D3DB-4D95-8B11-EA0E769C34B4Q30541996-8518DA40-21E1-4AD3-8DF3-23475CC064E8Q33727268-75D454A1-E4D1-44FD-8D5B-0C0EDE7D2E7AQ35719609-46AA6AC9-7A12-49BB-84A7-3505FF15397BQ36055556-FA8B5A91-C25B-4D39-8FE9-0CDC2D3425E6Q37069901-702E5E1F-A460-4EDE-9715-EDFE2CE9E83EQ37673214-9DFC5C40-1CF0-4AC0-9D80-2C19B979D140Q37898562-287D23B4-D3A8-4938-8A47-E8F17710EF69Q38055457-1333D217-9F38-4144-96B7-241B074901F1Q38118187-F47DA120-145C-4ABF-B727-D5C6FA4EEC31Q38371329-2BBFA1D3-7699-46B6-BA30-C9D0841ACB95Q38951947-98B36E87-EFAB-437B-9CB0-1DC361033A35Q45814315-F28F7BF8-7555-4403-AF87-823162122A06Q46132067-8D916297-2AB7-4A3C-8436-7BC644CD049FQ47915476-D2442A21-9329-4D44-B988-E731C4228445Q48474282-20C01CAF-E7AE-453A-832E-631C3292F300Q58739806-7BC0BE39-EC0E-425C-8702-2DD18C98E56A
P2860
Use of non-steroidal anti-inflammatory drugs and risk of Parkinson's disease: nested case-control study.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Use of non-steroidal anti-infl ...... se: nested case-control study.
@ast
Use of non-steroidal anti-infl ...... se: nested case-control study.
@en
Use of non-steroidal anti-infl ...... se: nested case-control study.
@nl
type
label
Use of non-steroidal anti-infl ...... se: nested case-control study.
@ast
Use of non-steroidal anti-infl ...... se: nested case-control study.
@en
Use of non-steroidal anti-infl ...... se: nested case-control study.
@nl
prefLabel
Use of non-steroidal anti-infl ...... se: nested case-control study.
@ast
Use of non-steroidal anti-infl ...... se: nested case-control study.
@en
Use of non-steroidal anti-infl ...... se: nested case-control study.
@nl
P2093
P2860
P356
P1433
P1476
Use of non-steroidal anti-infl ...... se: nested case-control study.
@en
P2093
J Michael Gaziano
Jane A Driver
P2860
P356
10.1136/BMJ.D198
P407
P577
2011-01-20T00:00:00Z